Frare André Luiz

Regenerative Medicine Department, Brazilian Society of Pain -Pain Treatment Center, Brazil

*Corresponding Author: Frare André Luiz, Regenerative Medicine Department, Brazilian Society of Pain -Pain Treatment Center, Brazil.

Received: March 09, 2023; Published: April 11, 2023

Abstract

Within the area of Regenerative Medicine, the advances for the treatment of Osteoarthritis and Osteoarthrosis are already a reality. Grade 1, 2, 3 and 4 arthrosis receive a special treatment called joint infiltrations, which can be performed with corticosteroids and also with hyaluronic acid gel, called Visco supplementation. The most qualified professional to perform this procedure is the Physical Therapist.

Keywords: Osteoarthritis; Osteoarthrosis; Pysical Therapist; Viscosupplmentation; Infiltrations; Corticosteroids

References

1. BARNES Peter J., et al. “Anti-inflammatory actions of steroids: Molecular mechanisms”. Trends in Pharmacological Sciences 14 (1993): 436-441.
2. BARRACLOUGH D. “The use of corticosteroid agents in connective tissue disorders”. The Medical Journal of Australia 144 (1986): 427-432.
3. BELLAMY N., et al. “Viscosupplementation for the treatment of osteoarthritis of the knee”. Cochrane Database of Systematic Reviews 2 (2006): CD005321.
4. BEHRENS F., et al. “Alteration of rabbit articular cartilage by intra-articular injections of glucocorticoids”. The Journal of Bone and Joint Surgery 57 (1975): 70-76.
5. BJORDAL JM., et al. “Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: A meta-analysis of randomised placebo-controlled trials”. European Journal of Pain 2 (2007): 125-138.
6. BLYTH T., et al. “Pain relief in the rheumatoid knee after steroid injection. A single-blind comparison of hydrocortisone succinate and triamcinolone acetonide or hexacetonide”. British Journal of Rheumatology 33 (1994): 461-463.
7. CAMPOS GC., et al. “Evaluation of the effect of adding corticosteroid to viscosupplementation”. a prospective and randomized study [poster 511]. In: World Congress on Osteoarthritis, San Diego, CA (2011).
8. CENTENO LM and MOORE ME. “Preferred intraarticular corticoids and associated practice: A survey of members of the American College of Rheumatology”. Arthritis Care and Research 7 (1994): 151-155.
9. CILWAIN H., et al. “Intra-articular orgote in osteoarthritis of the knee: a placebo-controIled efficacy, safety and dosage comparison”. The American Journal of Medicine 87 (1989): 295-300.
10. CHING DW., et al. “Injection therapy of superficial rheumatoid nodules”. British Journal of Rheumatology 31 (1992): 775-777.
11. CHATHAM WW., et al. “lntraarticular injection: should we rest the joints?” Arthritis and Rheumatology 32 (1989): 70-74.
12. CONROZIER T., et al. “Intra articular injections of Hylan GF-20 reduce type 2 collagen degradation in patients with knee osteoarthritis: the biovisco study”. Annals of Rheumatic Diseases 3 (2010): 281.
13. DIEPPE PA., et al. “Intra-articular steroids in osteoarthritis”. Rehabilitation in Rheumatology 19 (1980): 212-217.
14. DIVINE JG., et al. “Viscosupplementation for knee osteoarthritis: a systematic review”. Clinical Orthopaedics and Related Research 455 (2007): 113-122.
15. EMKEY Ronald D., et al. “The systemic effect of intra-articular administration of corticosteroids on markers of bone formation and bone resorption in patients with rheumatoid arthritis”. Arthritis and Rheumatology 39 (1996): 277-282.
16. ESENYEL M., et al. “Treatment of myofascial pain”. American Journal Physical Medicine and Rehabilitation 79 (2000): 48-52.
17. EYMONTT MJ., et al. “The effects on synovial permeability and synovial fluid leukocyte counts in symptomatic osteoarthritis after intraarticular corticosteroids administration”. The Journal of Rheumatology 9 (1982): 198-203.
18. FIRESTEIN GS., et al. “Gene expresion (collagenase, tissue inhibitor of metalloproteases, complement, and HLA DR) in rheumatoid arthritis and osteoarthritis synovium. Quantitative analisys and effect of intra articular corticosteroids”. Arthritis and Rheumatology 34 (1991): 1094-1105.
19. FRIEDMAN DM and MOORE ME. “The efficacy of intraarticular steroids in osteoarthritis: a double-blind study”. The Journal of Rheumatology 7 (1980): 850-856.
20. GIBSON T., et al. “Effect of intra-articular corticosteroid injections on primate cartilage”. Annals of the Rheumatic Diseases 36 (1977): 74-79.
21. GARVEY TA., et al. “A prospective, randomized, double-blind evaluation of trigger-point injection therapy for low-back pain”. Spine 14 (1989): 962-964.
22. GRAY Robert G., et al. “Local corticosteroid injection treatment in rheumatic disorders”. Seminars in Arthritis and Rheumatism 10 (1981): 231-254.
23. GRAY Robert G and GOTTLIEB Norman L. “lntra-articular corlicosteroids: an updated assessment”. Clinical Orthopaedics and Related Research 177 (1983): 253-263.
24. GOTTLIEB Norman L and RISKIN Wayne G. “Complications of local corticosteroids injections”. JAMA 243 (1980): 1547-1548.
25. GILSANZ V and BERNSTEIN BH. “Joint calcification following intraarticular corticosteroid therapy”. Radiology 151 (1984): 647-649.
26. GOETZL EJ., et al. “Effects of intrarticular corticosteroids in vivo on synovial fluid variables in rheumatoid synovitis”. Annals of Rheumatic Diseases 33 (1874): 62-66.
27. HENDERSON EB., et al. “lntra-articular injections of 750 kD hyaluronan in the treatment of osteoarthritis: a randomised single centre double-blind placebo controlled trial of 91 patients demonstrating lack of efficacy”. Annals Rheumatic Diseases 53 (1994): 529-534.
28. HEYBELI N., et al. “[Intra-articular sodium hyaluronate injections after arthroscopic debridement for osteoarthritis of the knee: a prospective, randomized, controlled study]”. Acta Orthopaedica et Traumatologica Turcica 4 (2008): 221-227.
29. , et al. “Intra-synovial cortícosteroid therapy: a decade of use”. Bulletin on the Rheumatic Diseases 11 (1961): 239-240. 1961.
30. HOLLANDER Joseph., et al. “Hydrocortisone and cortisone injected into alihritic joints: comparative effects of and use of hydrocortisone as a local antiarthritic”. JAMA 147 (1951): 1629-1635.
31. HOCHBERG MC., et al. “Guidelínes for the medical management of osteoarthritis”. Arthritis Rheumatism 38 (1995): 1541-1546.
32. , et al. “Intra-articular corticosteroids for crhonic arthritis in children: efficacy and effects on cartilage and growth”. The Journal Pediatrics 127 (1995): 317-321.
33. JUBB RW., et al. “A one-year, randomised, placebo (saline) controlled clinical trial of 500-730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee”. International Journal of Clinical Practice6 (2003): 467-474.
34. KENNEDY lC and WILLIS RB. “The effects of local steroid injections on tendons: A biochemical and microscopic correlative study”. The American Journal of Sports Medicine 4 (1976): 11-21.
35. KEMPER F., et al. “Tolerability and short-term effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice”. Current Medical Research and Opinion8 (2005): 1261-1269.
36. MAZIERES B., et al. “A French controlled multicenter study of intraarticular orgote in versus intraarticular corticosteroids in the treatment of knee osteoarthritis: a one-year followup”. The Journal of Rheumatology 27 (1991): 134-137.
37. MCCLAFLIN Richard R. “Myofascial pain syndrome. Primary care strategies for early intervention”. Postgraduate Medicine 96 (1994): 56-73.
38. MCCARTHY GM and MCCARTHY DJ. “Intra-synovial corticosteroid therapy”. Bulletin on the Rheumatic Diseases 43 (1994): 2-4.
39. MCCARTY DJ. “Treatment of rheumatoid joint inf ammahon with triamcinolonehexacetonide”. Arthritis and Rheumatology 15 (1992): 157-173.
40. MCCARTY Daniel J and HOGAN Joseph M. “Inflammatory reaction after intrasynovial injection of microcrystalline adrenocorticosteroid esters”. Arthritis and Rheumatism 7 (1964): 359-367.
41. MEYER K. “Chemical structure of hyaluronic acid”. Federation Proceedings 4 (1958): 1075-1077.
42. OWEN DS. “Aspiration and injection of joint and soft tissues”. In: KELLY, W.N.; HARRIS, E.D.; RUDDY, S.; SLEDGE, C.B. Textbook of Rheumatology. Philadelphia: WB Saunders Company, (1997): 591-608.
43. PELLETIER JP., et al. “The in vivo effects of intraarticular corticosteroid injections on cartilage lesions, stromelysin, interleukin-I, and oncogene protein synthesis in experimental osteoarthritis”. Laboratory Investigation 72 (1995): 578-586.
44. PFENNINGERM JL. “Injections of joints and soft tissues: Part 1. General Guidelines”. Primary Care 11 (1984): 211-218.
45. QUIRÓS FJ. “Infiltraciones articulares y de partes blandas con glucocorticoides. Generalidades”. Medifam 9 (2006): 120-128.
46. STEFANICH RJ. “Intra-articular corticosteroids in treatment of osteoarthritis”. Orthopedic Reviews 15 65-71.
47. SIMONS Lee S. “Viscosupplementation therapy with intra-articular hyalhuronic acid”. Rheumatic Disease Clinics of North America 25 (1999): 345-357.
48. SASAKIA SASAKI K., et al. “Hyaluronate inhibits the interleukin-1beta-induced expression of matrix metalloproteinase (MMP)-1 and MMP-3 in human synovial cells”. The Tohoku Journal of Experimental Medicine 2 (2004): 99-107.
49. YASUDA T. “Hyaluronan inhibits prostaglandin E2 production via CD44 in U937 human macrophages”. The Tohoku Journal of Experimental Medicine 3 (2010): 229-235.
50. ZUCKERNLAN JD., et al. “Injections for joint and soft tissue disorders: when and how to use them”. Geriatrics 45 (1990): 45-52.

Citation

Citation: Frare André Luiz. “Clinical Use Drugs for Joint Infiltrations of the Locomotor System”.Acta Scientific Orthopaedics 6.5 (2023): 32-39.

Copyright

Copyright: © 2023 Frare André Luiz. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.